These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 35662611)

  • 1. Severe dawn phenomenon predicts long-term risk of all-cause mortality in patients with type 2 diabetes.
    Cai J; Peng P; Lu J; Shen Y; Wang C; Mo Y; Lu W; Zhu W; Xia T; Zhou J
    Diabetes Metab Res Rev; 2024 May; 40(4):e3813. PubMed ID: 38767128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic status, insulin resistance, and mortality from lung cancer among individuals with and without diabetes.
    Cho IY; Chang Y; Sung E; Park B; Kang JH; Shin H; Wild SH; Byrne CD; Ryu S
    Cancer Metab; 2024 Jun; 12(1):17. PubMed ID: 38902745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the temporal within-day glycemic variability during hospitalization in patients with type 2 diabetes patients using continuous glucose monitoring: a retrospective observational study.
    Xing Y; Wu M; Liu H; Li P; Pang G; Zhao H; Wen T
    Diabetol Metab Syndr; 2024 Mar; 16(1):56. PubMed ID: 38429847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter?
    Mo Y; Lu J; Zhou J
    J Diabetes Investig; 2024 Jan; 15(1):5-14. PubMed ID: 37988220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of glycemic variability with death and severe consciousness disturbance among critically ill patients with cerebrovascular disease: analysis of the MIMIC-IV database.
    Cai W; Li Y; Guo K; Wu X; Chen C; Lin X
    Cardiovasc Diabetol; 2023 Nov; 22(1):315. PubMed ID: 37974159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic variability and in-hospital death of critically ill patients and the role of ventricular arrhythmias.
    Su Y; Fan W; Liu Y; Hong K
    Cardiovasc Diabetol; 2023 Jun; 22(1):134. PubMed ID: 37308889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure.
    Chun KH; Oh J; Lee CJ; Park JJ; Lee SE; Kim MS; Cho HJ; Choi JO; Lee HY; Hwang KK; Kim KH; Yoo BS; Choi DJ; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Kang SM
    Cardiovasc Diabetol; 2022 Dec; 21(1):291. PubMed ID: 36575485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application guidelines for blood glucose monitoring in China (2022 edition).
    Bao Y; Zhu D;
    Diabetes Metab Res Rev; 2022 Nov; 38(8):e3581. PubMed ID: 36251516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.
    Yapanis M; James S; Craig ME; O'Neal D; Ekinci EI
    J Clin Endocrinol Metab; 2022 May; 107(6):e2221-e2236. PubMed ID: 35094087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of short-term glycemic variability on risk of all-cause mortality in type 2 diabetes patients with well-controlled glucose profile by continuous glucose monitoring: A prospective cohort study.
    Mo Y; Wang C; Lu J; Shen Y; Chen L; Zhang L; Lu W; Zhu W; Xia T; Zhou J
    Diabetes Res Clin Pract; 2022 Jul; 189():109940. PubMed ID: 35662611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes.
    Lu J; Wang C; Cai J; Shen Y; Chen L; Zhang L; Lu W; Zhu W; Hu G; Xia T; Zhou J
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3160-3167. PubMed ID: 34279663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
    Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
    Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
    Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.